Invesco
THRD

Invesco’s Third Harmonic Bio THRD Stock Holding History

Invesco’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-265,134
Closed -$3.59M – 3810
2024
Q3 		$3.59M Sell
265,134
-5,855
-2% -$72.5K ﹤0.01% 2395
2024
Q2 		$3.52M Buy
+270,989
New +$3.35M ﹤0.01% 2354
2024
Q1 		– Sell
-265,074
Closed -$2.91M – 3940
2023
Q4 		$2.91M Buy
+265,074
New +$2.1M ﹤0.01% 2478

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco's THRD Position: Q4 2024 in Review

Invesco sold out of Third Harmonic Bio (THRD) in Q4 2024, closing a stake of 265,134 shares — an estimated $3.59M sold.

Invesco first reported a position in THRD in Q4 2023 and held it in 3 quarters. The position peaked at $3.59M in Q3 2024. 96 funds tracked by Wall St. Rank hold THRD as of Q4 2024.

  • Invesco reported no remaining Third Harmonic Bio position as of Q4 2024 after selling out during the quarter.
  • Invesco sold 265,134 Third Harmonic Bio shares in Q4 2024, an estimated $3.59M.
  • Invesco first reported a position in Third Harmonic Bio in Q4 2023 and held it in 3 quarters.
  • Invesco's Third Harmonic Bio position peaked at $3.59M in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2024.

Based on Invesco's 13F filing for Q4 2024, filed 13 Feb 2025.